Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
276,203,256
-
Share change
-
+12,116,368
-
Total reported value
-
$9,708,565,984
-
Put/Call ratio
-
36%
-
Price per share
-
$35.14
-
Number of holders
-
788
-
Value change
-
+$516,369,806
-
Number of buys
-
368
-
Number of sells
-
335
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q4 2022
As of 31 Dec 2022,
GSK plc - SPONSORED ADR (GSK) was held by
788 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
276,203,256 shares.
The largest 10 holders included
Dodge & Cox, JTC Employer Solutions Trustee Ltd, FMR LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, GOLDMAN SACHS GROUP INC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, and Point72 Asset Management, L.P..
This page lists
788
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.